Multiple Antibiotics Resistance Index of both Gram-positive and Gram- Negative Bacteria Isolated from Diabetic patients attending General hospital Minna, Niger State, Nigeria
A 2025 cross-sectional study at General Hospital Minna, Nigeria, revealed a high prevalence (71%) of multidrug-resistant uropathogens, predominantly *E. coli* and *S. aureus*, among diabetic patients, highlighting the urgent need for routine antimicrobial susceptibility testing to guide effective therapy.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In many parts of the world, a simple infection that once cleared up with a standard pill can now linger stubbornly, refusing to yield to treatment. This growing challenge stems from a phenomenon where bacteria evolve to survive the very medicines designed to kill them, a process known as antimicrobial resistance. When a patient contracts a urinary tract infection, it is often caused by microscopic organisms that naturally inhabit the body or enter from the environment. In people with diabetes, the risk of these infections is higher because elevated blood sugar levels can weaken the immune system and create a favorable environment for bacterial growth. The danger lies not just in the infection itself, but in the possibility that the bacteria causing it have become resistant to multiple drugs, leaving doctors with few options to cure the patient. Understanding which specific bacteria are causing these infections and which medicines still work against them is essential for keeping communities healthy.
Researchers recently set out to investigate this exact problem at the General Hospital in Minna, Nigeria, focusing on patients who had been diagnosed with diabetes. Over the course of nearly a year, the team collected urine samples from four hundred individuals, looking for the presence of harmful bacteria. They were interested in both those who showed clear symptoms of a urinary tract infection and those who carried the bacteria without feeling sick, a condition known as asymptomatic bacteriuria. By growing these samples in a laboratory, the scientists were able to identify the specific types of bacteria present and test how they reacted to a wide range of common antibiotics. This process allowed them to map out the landscape of infection in this specific group of patients, revealing which microbes were most common and how difficult they were to treat.
The study found that infections were widespread among the participants, with more than two-thirds of the patients carrying uropathogens, the bacteria that cause urinary tract infections. Among those with confirmed bacterial growth, the most common culprit was a bacterium called Escherichia coli, which accounted for nearly a third of all cases. This was followed by Staphylococcus aureus, a type of bacteria often found on the skin, and several other species including Proteus mirabilis, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The researchers observed that women were more likely to carry these infections than men, and that the prevalence of bacteria increased with age, particularly in patients over forty. Furthermore, the data showed a clear link between the severity of diabetes and the presence of infection; patients with higher blood sugar levels were significantly more likely to harbor these bacteria.
Perhaps the most critical finding of the study was the high level of resistance these bacteria showed to standard medications. When the team tested the isolated bacteria against a variety of antibiotics, they discovered that many of the organisms were immune to several of the most commonly prescribed drugs. Both the Gram-positive and Gram-negative bacteria, which are two major categories of bacteria distinguished by their cell wall structures, demonstrated strong resistance to medications like amoxicillin, ceftazidime, and erythromycin. In fact, a large portion of the bacteria tested were classified as multidrug-resistant, meaning they could survive exposure to three or more different classes of antibiotics. For instance, nearly all the Staphylococcus aureus samples were resistant to amoxicillin and rifampicin, while the majority of Escherichia coli samples could not be stopped by ceftazidime.
The researchers calculated a specific index to measure how many different antibiotics each bacterial strain could resist, finding that the resistance levels were alarmingly high across the board. This suggests that the bacteria circulating in this hospital setting have adapted to survive a broad spectrum of treatments, likely due to the frequent and sometimes improper use of antibiotics in the community. The study highlighted that factors such as a patient's age, gender, and the duration of their diabetes played a role in which bacteria they carried, but the overarching trend was one of increasing drug resistance. The authors concluded that the current situation represents a rising burden of difficult-to-treat infections among diabetic patients in the region.
To address this growing threat, the study emphasizes the need for routine testing before prescribing medication. Rather than guessing which antibiotic might work, doctors should regularly check the susceptibility of the bacteria causing an infection to ensure the chosen treatment is effective. This approach, known as antimicrobial stewardship, helps prevent the further spread of resistant strains and ensures that patients receive the right care. The findings from Minna serve as a reminder that the battle against bacterial infections is constantly evolving, and that local data is crucial for guiding treatment strategies in hospitals and clinics. Without such careful monitoring, the effectiveness of existing medicines could continue to erode, leaving patients with fewer and fewer options for recovery.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.